Tokyo, Japan
Tokyo, Japan

Time filter

Source Type

Patent
Teijin Pharma Ltd | Date: 2016-11-01

For reducing a discomfort feeling brought by wearing a breathing mask, a wearing tool for the breathing mask which covers nostrils of a user and supplies gas for breathing to the nostrils comprises a pair of connecting members each of which has a longitudinal shape and has a first end portion which is connected to the breathing mask, and a pair of fixing members each of which is connected to a second end portion of the fixing member and is plugged in the tragus of the user. Hence a discomfort feeling due to restraining around the head of the user can be reduced.


Patent
Teijin Pharma Ltd | Date: 2017-03-22

Provided is a novel pyrazine derivative represented by the following formula (I) or a pharmaceutically acceptable salt thereof, or a solvate thereof which is useful for treating or preventing diseases in which URAT1 is involved, including gout, hyperuricemia, hypertension, renal diseases such as interstitial nephritis and the like, diabetes, arteriosclerosis, Lesch-Nyhan syndrome, and the like.


Disclosed are crystals of 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid useful as therapeutic or prophylactic agents for gout, hyperuricemia, and the like, and a method for producing the crystals.


A rehabilitation assistance device (1), provided with: an arm part (30) having a holding part (20) for holding a part of the upper limb or the lower limb of a user, the arm part (30) movably supporting the holding part (20); a memory unit (80) for storing training information, the memory unit (80) storing first training information defined in advance; a motion information acquisition unit (61) for acquiring motion information associated with the movement of the holding part (20), the motion information acquisition unit (61) acquiring first motion information for the holding part (20) moved on the basis of the first training information; a motion evaluation unit (72) for generating evaluation information in which the motion information is evaluated, the motion evaluation unit (72) evaluating the first motion information and generating first evaluation information; and a display (40) for displaying at least one of the training information, the motion information, and the evaluation information.


Patent
Teijin Pharma Ltd and Amgen Inc. | Date: 2017-01-04

The present invention relates to a novel compound having a function of inhibiting ROR activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.


Patent
Teijin Pharma Ltd | Date: 2017-05-31

Provided are a means to detect a plurality of dynamics, a processing unit that calculates a temporal change in the detected dynamics, and an evaluation device that determines exacerbation of clinical conditions in heart failure of a patient based on the calculated change in the patients dynamics over time. The present invention makes it possible to detect, early and with high accuracy, that the onset of acute heart failure is imminent.


Patent
Teijin Pharma Ltd | Date: 2016-06-03

The purpose of the present invention is to provide a novel therapeutic or prophylactic agent for tumor lysis syndrome. The present invention is a therapeutic or prophylactic agent for tumor lysis syndrome, which comprises a 2-phenylthiazole compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.


Patent
Teijin Pharma Ltd | Date: 2016-04-06

The present invention provides a gas supply apparatus (400) comprising: means (414) for detecting a users respiration; a product gas flow path on-off valve (412) having a function to start and stop output of the product gas in synchronization with the users respiration; and an ultrasonic type gas concentration and flow rate measuring means (410) having two ultrasonic transducers (420) disposed in an opposed manner in the line (422) through which the product gas flows, wherein a concentration value measured when said product gas output is stopped is determined to be a product gas concentration. As the oxygen concentration is measured while the output of the product gas flow is stopped in synchronization with the users respiration, even in the respiratory synchronous type gas supply apparatus, the ultrasonic type gas concentration and flow rate measuring means can measure the oxygen concentration of the product gas accurately.


Patent
Teijin Pharma Ltd | Date: 2016-02-10

Provided is a magnetic stimulation device, which does not feel hot to the user. The magnetic stimulation device (1) comprises: a contact plate (2) to be disposed near the users head; an exciting coil (3) to be held above the contact plate (2) ; a casing (4), which covers at least the upper side of the exciting coil (3), in which openings (17, 18) are provided above the center of the exciting coil (3) winding, and in which a gap that is open on the outside of the exciting coil (3) is formed between the casing and the contact plate (2) ; and a suction fan (5) for drawing out air between the contact plate (2) and the casing (4) from the openings (17, 18) of the casing (4).


Provided is an inexpensive device capable of accurately positioning a medical instrument relative to the head of a user. A head positioning device (7) is used. The head positioning device (7) is provided with: a pair of holding members (11, 12) which holds the face of a user from both sides by elasticity and prevents both the forward tilting of the users head and the rotation of the neck; a neck rest (13) which comes into contact with the back side of the users neck and determines the position of the neck in the front-rear direction; and a head-back rest (14) which comes into contact with the back of the head and which prevents the head from tilting backward.

Loading Teijin Pharma Ltd collaborators
Loading Teijin Pharma Ltd collaborators